GGHC
SCMP

Gilder Gagnon Howe & Co’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-63,082
Closed -$1.25M – 280
2015
Q3 		$1.25M Sell
63,082
-21,748
-26% -$499K 0.02% 182
2015
Q2 		$1.39M Buy
84,830
+147
+0.2% +$2.55K 0.02% 203
2015
Q1 		$1.32M Buy
+84,683
New +$1.31M 0.02% 198

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Gilder Gagnon Howe & Co's SCMP Position: Q4 2015 in Review

Gilder Gagnon Howe & Co sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2015, closing a stake of 63,082 shares — an estimated $1.25M sold.

Gilder Gagnon Howe & Co first reported a position in SCMP in Q1 2015 and held it in 3 quarters. The position peaked at $1.39M in Q2 2015. 149 funds tracked by Wall St. Rank hold SCMP as of Q4 2015.

  • Gilder Gagnon Howe & Co reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 63,082 Sucampo Pharmaceuticals, Inc. shares in Q4 2015, an estimated $1.25M.
  • Gilder Gagnon Howe & Co first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Gilder Gagnon Howe & Co's Sucampo Pharmaceuticals, Inc. position peaked at $1.39M in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2015, filed 4 Feb 2016.